MED
Medifast Inc
Price:  
13.99 
USD
Volume:  
341,015
United States | Personal Products

Medifast WACC - Weighted Average Cost of Capital

The WACC of Medifast Inc (MED) is 5.9%.

The Cost of Equity of Medifast Inc (MED) is 8%.
The Cost of Debt of Medifast Inc (MED) is 5%.

RangeSelected
Cost of equity6.3% - 9.7%8%
Tax rate23.2% - 23.7%23.45%
Cost of debt5.0% - 5.0%5%
WACC5.1% - 6.7%5.9%
WACC

Medifast WACC calculation

CategoryLowHigh
Long-term bond rate3.9%4.4%
Equity market risk premium4.6%5.6%
Adjusted beta0.530.86
Additional risk adjustments0.0%0.5%
Cost of equity6.3%9.7%
Tax rate23.2%23.7%
Debt/Equity ratio
11
Cost of debt5.0%5.0%
After-tax WACC5.1%6.7%
Selected WACC5.9%

Medifast's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for Medifast:

cost_of_equity (8.00%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.53) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.